| abstract |
Use of mycosporin-like amino acid (M-gly) in products for prevention and treatment of actinic erythema, photocarcinogenesis and photoaging. The present invention is part of the biotechnology sector and describes the potential use of a mycosporin-like amino acid, specifically of M-gly isolated from Lichyna pygmaea marine lichen, in addition to its possible application in pharmaceutical, nutraceutical, or functional food preparations, among others, for the prevention and therapeutic treatment of actinic erythema, photocarcinogenesis and photoaging. |